Efthymios Deliargyris
CIK 1751617 · Chief Medical Officer · last filed 2025-08-08
Efthymios Deliargyris is a Chief Medical Officer who has filed 13 SEC Form 4 insider transactions across 2 companies since 2018. The most recent filing, for CTSO, was dated Aug 8, 2025. Across all open-market trades the lifetime net is +$30.0K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $189.1K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$189.1K
2
13
$30.0K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CTSO | Chief Medical Officer | 473,025 | $0.40 | $189.1K | $30.0K | 10 | 2025-08-08 |
| PLx Pharma Inc. (PLXP) Delisted | Chief Medical Officer | — | $0.09 | — | $0 | 3 | 2020-03-24 |
Recent Filings
13 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-08-08 | CTSO | Grant (A) | +70,000 | $0 | EDGAR |
| 2025-01-22 | CTSO | Mixed | +16,233 | $16.2K | EDGAR |
| 2024-10-08 | CTSO | Grant (A) | — | $0 | EDGAR |
| 2024-04-04 | CTSO | Grant (A) | +61,000 | $0 | EDGAR |
| 2024-04-02 | CTSO | Grant (A) | — | $0 | EDGAR |
| 2023-12-15 | CTSO | Buy (P) | +22,557 | $30.0K | EDGAR |
| 2023-07-11 | CTSO | Grant (A) | +55,000 | $0 | EDGAR |
| 2022-08-12 | CTSO | Grant (A) | +107,000 | $0 | EDGAR |
| 2021-04-14 | CTSO | Grant (A) | +40,000 | $359.6K | EDGAR |
| 2020-05-05 | CTSO | Grant (A) | +140,000 | $0 | EDGAR |